MERSANA THERAPEUTICS INC's ticker is MRSN and the CUSIP is 59045L106. A total of 157 filers reported holding MERSANA THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.08 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,368,032 | +6.6% | 5,801,600 | +176.3% | 2.23% | +4.5% |
| Q2 2023 | $6,909,000 | +211.3% | 2,100,000 | +288.8% | 2.14% | +133.3% |
| Q1 2023 | $2,219,642 | -66.8% | 540,059 | -52.6% | 0.92% | -52.1% |
| Q4 2022 | $6,681,467 | -0.6% | 1,140,182 | +14.7% | 1.91% | -15.9% |
| Q3 2022 | $6,720,000 | +71.1% | 994,073 | +16.9% | 2.27% | +88.0% |
| Q2 2022 | $3,927,000 | +131.1% | 850,000 | +579.3% | 1.21% | +59.5% |
| Q2 2021 | $1,699,000 | +319.5% | 125,123 | +400.5% | 0.76% | +243.0% |
| Q1 2021 | $405,000 | +41.6% | 25,000 | +132.3% | 0.22% | +33.1% |
| Q4 2020 | $286,000 | – | 10,763 | – | 0.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 4,005,600 | $64,810,000 | 6.21% |
| Bain Capital Life Sciences Investors, LLC | 3,695,667 | $59,796,000 | 3.39% |
| COMMODORE CAPITAL LP | 429,228 | $6,945,000 | 2.77% |
| ACUTA CAPITAL PARTNERS, LLC | 357,689 | $5,787,000 | 2.09% |
| Avoro Capital Advisors LLC | 6,800,000 | $110,024,000 | 1.90% |
| Ghost Tree Capital, LLC | 450,000 | $7,281,000 | 1.71% |
| RHO CAPITAL PARTNERS INC | 796,458 | $12,887,000 | 1.24% |
| Rock Springs Capital Management LP | 2,775,127 | $44,902,000 | 0.98% |
| Sio Capital Management, LLC | 157,259 | $2,544,000 | 0.52% |
| Bellevue Group AG | 2,850,010 | $46,113,000 | 0.49% |